Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptyingpreclinical evidence
They not only aid in the weight loss process, but provide the body with much needed essential vitamins and minerals it is lacking
The expected publication date for the guideline is yet to be determined
A doctor may recommend weight loss for people with overweight or obesity
It gained popularity for its once-weekly dosing schedule, something that most other GLP-1 receptor agonists now match
Using logistic regression models, they estimated propensity scores that incorporated demographics, comorbidities, immunosuppressive medication use, COVID-19 vaccination, and prior infection, and subsequently performed inverse probability treatment weighting (IPTW)